GRP
ELEV

Global Retirement Partners’s Elevation Oncology ELEV Stock Holding History

Global Retirement Partners’s Portfolio ELEV Stock Details ELEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$5.63K Buy
+10,000
New +$5.9K ﹤0.01% 2630

Other funds holding ELEV

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Global Retirement Partners's ELEV Position: Q4 2024 in Review

Global Retirement Partners opened a new position in Elevation Oncology (ELEV) in Q4 2024: 10,000 shares worth $5.63K. The stake represents ﹤0.01% of the portfolio and ranks #2630 among its holdings.

71 funds tracked by Wall St. Rank hold ELEV as of Q4 2024.

  • Global Retirement Partners held 10,000 shares of Elevation Oncology worth $5.63K as of Q4 2024.
  • Elevation Oncology was a new Global Retirement Partners position in Q4 2024.
  • Elevation Oncology made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2024, its #2630 holding.
  • 71 funds tracked by Wall St. Rank held Elevation Oncology as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.